Ramsey Healthcare – FY17 Earnings

Ramsey reported FY17 NPAT in line with guidance at A$543 million, up +12.7% on the same time last year. Revenue was also in line at A$8.7 billion.

All divisions contributed to earnings growth with Australia & Asia as the standout.

You’re not a member!  Trial today

Assuming underlying EPS growth of 15% into FY18, we have Ramsey on a 2.2% forward yield, as dividends increase to $1.45 per share.

We view Ramsey as a strong buying opportunity on the next higher low formation, or Algo Engine buy signal.

 

 

Ready to elevate your investing?

Join Investor Signals today and start your journey to better, more disciplined returns.